Skip to main content
Veterinary Medicines

Porcilis Ery+Parvo, suspenzija za injekciju za svinje

Not authorised
  • Porcine parvovirus, strain 014, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated

Product identification

Medicine name:
Porcilis Ery+Parvo, suspenzija za injekciju za svinje
Active substance:
  • Porcine parvovirus, strain 014, Inactivated
  • Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
Target species:
  • Pig (female)
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Porcine parvovirus, strain 014, Inactivated
    552.00
    enzyme-linked immunosorbent assay unit
    /
    1.00
    Dose
  • Erysipelothrix rhusiopathiae, serotype 2, strain M2, Inactivated
    1.00
    Protective Dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Pig (female)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI09AL01
Authorisation status:
  • Surrendered
Authorised in:
  • Croatia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Intervet International B.V. Subsidiary In The Republic Of Croatia
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International B.V.
Responsible authority:
  • Ministry Of Agriculture Veterinary And Food Safety Directorate
Authorisation number:
  • UP/I-322-05/13-01/576
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Croatian (PDF)
Published on: 18/02/2022
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."